Literature DB >> 17695471

Occurence of stromal myofibroblasts in the invasive ductal breast cancer tissue is an unfavourable prognostic factor.

Pawel Surowiak1, Dawid Murawa, Verena Materna, Adam Maciejczyk, Marek Pudelko, Slawomir Ciesla, Jan Breborowicz, Pawel Murawa, Maciej Zabel, Manfred Dietel, Hermann Lage.   

Abstract

BACKGROUND: Numerous experimental studies have described the capacity of myofibroblasts to stimulate mammary cancer cells in a paracrine manner. Until now, the prognostic significance of myofibroblasts present in breast cancer has not been examined. PATIENTS AND METHODS: In paraffin sections, originating from 45 patients with primary invasive breast cancer, immunohistochemical reactions were performed using antibodies directed against smooth muscle actin, Ki-67, VEGF, bFGF and UPA.
RESULTS: The cases with higher content of myofibroblasts in the tumour tissue manifested higher grade, more pronounced expression of Ki-67, VEGF and bFGF and shorter overall survival and relapse-free survival.
CONCLUSION: The present study for the first time documents the unfavourable prognostic significance of myofibroblasts in tissues of invasive ductal mammary carcinomas.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17695471

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  37 in total

1.  Gene expression profiles during activation of cultured rat hepatic stellate cells by tumoral hepatocytes and fetal bovine serum.

Authors:  Yunhong Xia; Rongxin Chen; Zhenji Song; Shenglong Ye; Ruixia Sun; Qiong Xue; Zhe Zhang
Journal:  J Cancer Res Clin Oncol       Date:  2010-02       Impact factor: 4.553

2.  Inflammatory Components of the Thyroid Cancer Microenvironment: An Avenue for Identification of Novel Biomarkers.

Authors:  Tara Jarboe; Neha Y Tuli; Sanjukta Chakraborty; Rachana R Maniyar; Nicole DeSouza; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 3.  Cancer-associated fibroblasts as target and tool in cancer therapeutics and diagnostics.

Authors:  Elly De Vlieghere; Laurine Verset; Pieter Demetter; Marc Bracke; Olivier De Wever
Journal:  Virchows Arch       Date:  2015-08-11       Impact factor: 4.064

4.  Myofibroblasts in pulmonary and brain metastases of alveolar soft-part sarcoma: a novel target for treatment?

Authors:  Olga Genin; Gideon Rechavi; Arnon Nagler; Ofer Ben-Itzhak; Kellie J Nazemi; Mark Pines
Journal:  Neoplasia       Date:  2008-09       Impact factor: 5.715

5.  Active roles of tumor stroma in breast cancer metastasis.

Authors:  Zahraa I Khamis; Ziad J Sahab; Qing-Xiang Amy Sang
Journal:  Int J Breast Cancer       Date:  2012-02-19

6.  CD105 expression on CD34-negative spindle-shaped stromal cells of primary tumor is an unfavorable prognostic marker in early breast cancer patients.

Authors:  Leandro Marcelo Martinez; Vivian Labovsky; María de Luján Calcagno; Kevin Mauro Davies; Hernán Garcia Rivello; Hernán Garcia Rivello; Maria Silvia Bianchi; Alejandra Wernicke; Valeria Beatriz Fernández Vallone; Valeria Beatriz Fernández Vallone; Norma Alejandra Chasseing
Journal:  PLoS One       Date:  2015-03-24       Impact factor: 3.240

7.  Stromal infiltration of CD8 T cells is associated with improved clinical outcome in HPV-positive oropharyngeal squamous carcinoma.

Authors:  K Oguejiofor; J Hall; C Slater; G Betts; G Hall; N Slevin; S Dovedi; P L Stern; C M L West
Journal:  Br J Cancer       Date:  2015-08-27       Impact factor: 7.640

8.  Metabolic remodeling of the tumor microenvironment: migration stimulating factor (MSF) reprograms myofibroblasts toward lactate production, fueling anabolic tumor growth.

Authors:  Valentina Carito; Gloria Bonuccelli; Ubaldo E Martinez-Outschoorn; Diana Whitaker-Menezes; Maria Cristina Caroleo; Erika Cione; Anthony Howell; Richard G Pestell; Michael P Lisanti; Federica Sotgia
Journal:  Cell Cycle       Date:  2012-08-23       Impact factor: 4.534

9.  The role of tumour stroma in colorectal cancer invasion and metastasis.

Authors:  John Conti; Gareth Thomas
Journal:  Cancers (Basel)       Date:  2011-04-26       Impact factor: 6.639

Review 10.  The myofibroblast: phenotypic characterization as a prerequisite to understanding its functions in translational medicine.

Authors:  B Eyden
Journal:  J Cell Mol Med       Date:  2007-12-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.